OptiNose
OPTN
OPTN was delisted on the 20th of May, 2025.
64 hedge funds and large institutions have $271M invested in OptiNose in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 7 closing their positions.
88% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 16
87% more capital invested
Capital invested by funds: $144M → $271M (+$126M)
0.45% more ownership
Funds ownership: 3.8% → 4.25% (+0.45%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 67 → 64 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SW
SVB Wealth
Boston,
Massachusetts
|
+$15.3M |
| 2 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
+$5.56M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$3.52M |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$2.7M |
| 5 |
JP Morgan Chase
New York
|
+$1.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$1.86M |
| 2 |
BlackRock
New York
|
-$1.27M |
| 3 |
BC
Broadfin Capital
New York
|
-$966K |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$870K |
| 5 |
Two Sigma Investments
New York
|
-$646K |
OPTN Hedge Fund Activity: Q1 2019 in Review
64 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q1 2019, worth a combined $271M — up 87% from $144M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of OPTN and 4 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 30 added.
The largest buyer was SVB Wealth, opening a new position worth an estimated $15.3M. The largest seller was Tamarack Advisers, exiting entirely with an estimated $1.86M sold.
- 64 institutional investors held OptiNose (OPTN) as of Q1 2019, down from 67 in Q4 2018.
- Funds reported $271M of OptiNose stock for Q1 2019, up 87% quarter-over-quarter.
- 4 funds opened new OptiNose positions in Q1 2019 and 7 closed out, a net change of -3 holders.
- The largest OptiNose buyer in Q1 2019 was SVB Wealth, an estimated $15.3M added.
- The largest OptiNose seller in Q1 2019 was Tamarack Advisers, an estimated $1.86M sold.
Based on aggregated 13F filings for Q1 2019.